Arteris, Inc. (NASDAQ:AIP) director Saiyed Atiq Raza finalized the sale of a substantial block of common stock on June 1, 2026. Specifically, Mr. Raza sold a total of 70,000 shares, generating an aggregate value estimated at $2,521,103.
Crucially, these transactions were executed under the framework of a pre-established 10b5-1 trading plan. This specific plan was adopted by Mr. Raza on November 7, 2025, providing a structured mechanism for the sales.
Details of the Stock Transactions
The total divestiture of shares comprised two distinct segments. The initial portion involved the sale of 66,400 shares. For this segment, the weighted average selling price was determined to be $35.9922 per share. These sales were not monolithic; rather, they occurred across multiple transactions with individual prices varying between $35.34 and $36.33, collectively amounting to roughly $2,389,812.
The second transaction encompassed the sale of 3,600 shares. The weighted average price for this smaller group was calculated at $36.4503 per share. These shares were sold over a range of prices, from $36.34 up to $36.56, resulting in an approximate value of $131,221.
It is important to note the structure of ownership for these assets. All shares that were sold were held indirectly by the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust, with Mr. Raza serving in the capacity of trustee for this trust. Following the completion of these sales, Mr. Raza's indirect stake in Arteris common stock, channeled through the trust, now stands at 140,000 shares. Furthermore, Mr. Raza maintains a direct holding of 20,839 shares of the company's common stock.
The official documentation detailing these movements was filed as Form 4 and was signed by Paul Alpern, acting as Attorney-in-Fact for S. Atiq Raza, on June 3, 2026.
Market Context and Company Performance
This insider selling activity takes place against a backdrop of strong market performance for Arteris stock (NASDAQ:AIP). The stock was observed trading near its 52-week high mark of $38.47, having achieved an impressive cumulative return of 378% over the past year.
Analysis from InvestingPro suggests that, relative to its assessed Fair Value, the stock currently appears highly valued, placing it among companies identified as being significantly overpriced.
Recent Corporate Milestones Driving Momentum
In addition to the insider trading report, Arteris Inc. has recently communicated several positive corporate developments. The company reported robust financial outcomes for the first quarter of 2026, exceeding market expectations. Specifically, Arteris posted an earnings per share (EPS) figure of -$0.03, which surpassed the anticipated -$0.07. Revenue also proved strong, reaching $22.94 million and surpassing the forecasted amount of $21.03 million.
These positive financial results prompted action from industry analysts; TD Cowen subsequently increased its price target for Arteris shares to $40, up from a previous level of $22. They maintained their Buy rating on the stock. The firm's commentary highlighted both the company’s success during the first quarter and conveyed an optimistic outlook concerning the second quarter and the entirety of fiscal year 2026.
Furthermore, Arteris solidified its growing relevance in advanced technology sectors through significant partnerships. The company announced that Li Auto Inc. has incorporated its system IP technology into the L9 Livis SUV model. This integration utilizes Arteris FlexNoC 5 NoC interconnect IP and Magillem SoC integration automation software. This specialized technology is designed to support complex AI computational tasks, achieving a computing power of 2,560 trillion operations per second, underscoring Arteris's expanding role in both the automotive and artificial intelligence industries.